Advances in biopharmaceutical analysis in the People's Republic of China 1995-1997.
The present paper is the third biannual review in succession to the author's previous publications (Z.L. Qin, Advances in biopharmaceutical analysis in the People's Republic of China: 1991-1993, J. Pharm. Biomed Anal. 13, 1995, 1-7 and Z.L. Qin, Advances in biopharmaceutical analysis in the People's Republic of China: 1993-1995, J. Pharm. Biomed. Anal. 14, 1996, 1395-1403), regarding the methodological study and progress in biopharmaceutical analysis by RP-HPLC, GC and GC-MS selected from relative journals between April 1995 and March 1997 in P.R. China. The published methods were widely adopted in pharmacokinetic and metabolic studies. Investigation on drug metabolism were conducted more deeply, both in vitro and in vivo, for searching the structure of metabolites and drug metabolic pathways. The use of high performance CZE as a new trend for the analysis of drugs and metabolites in biofluids was also reported.
Qin
Z
Z
Department of Pharmaceutical Analysis, School of Pharmacy, Shanghai Medical University, PR China.
D001702:Biopharmaceutics; D002626:Chemistry, Pharmaceutical / Q000639:trends*; D002681:China; D002849:Chromatography, Gas / Q000379:methods; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000378:metabolism; D010599:Pharmacokinetics; D018675:Toxicity Tests
D004364:Pharmaceutical Preparations